Bennett Lawrence Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$2.98M Buy
145,480
+21,380
+17% +$445K 0.97% 41
2015
Q3
$2.66M Sell
124,100
-88,840
-42% -$1.98M 0.85% 45
2015
Q2
$4.26M Sell
212,940
-8,060
-4% -$142K 1.12% 33
2015
Q1
$3.44M Sell
221,000
-170,260
-44% -$2.57M 0.92% 44
2014
Q4
$5.38M Sell
391,260
-231,020
-37% -$2.83M 1.45% 30
2014
Q3
$6.22M Sell
622,280
-75,500
-11% -$772K 1.41% 33
2014
Q2
$6.92M Buy
697,780
+200,140
+40% +$1.77M 1.22% 34
2014
Q1
$5.15M Buy
497,640
+347,900
+232% +$3.6M 0.76% 49
2013
Q4
$1.33M Buy
+149,740
New +$1.19M 0.2% 72

Other funds holding DXCM

Bennett Lawrence Management's DXCM Position: Q4 2015 in Review

Bennett Lawrence Management increased its DexCom (DXCM) stake by 17% in Q4 2015, buying an estimated $445K and bringing the position to 145,480 shares worth $2.98M. The position accounts for 0.97% of the portfolio, ranked #41.

Bennett Lawrence Management first reported a position in DXCM in Q4 2013 and has held it in 9 quarters since. The position peaked at $6.92M in Q2 2014. 287 funds tracked by Wall St. Rank hold DXCM as of Q4 2015.

  • Bennett Lawrence Management held 145,480 shares of DexCom worth $2.98M as of Q4 2015.
  • Bennett Lawrence Management bought 21,380 DexCom shares in Q4 2015, an estimated $445K.
  • DexCom made up 0.97% of Bennett Lawrence Management's portfolio in Q4 2015, its #41 holding.
  • Bennett Lawrence Management first reported a position in DexCom in Q4 2013 and has held it in 9 quarters since.
  • Bennett Lawrence Management's DexCom position peaked at $6.92M in Q2 2014.
  • 287 funds tracked by Wall St. Rank held DexCom as of Q4 2015.

Based on Bennett Lawrence Management's 13F filing for Q4 2015, filed 16 Feb 2016.